Related Experiment Video
Updated: May 28, 2025
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
420
Critical Appraisal Tool for Homeopathic Intervention Studies: CATHIS
Katharina Gaertner1, Robert G Hahn2, Radmila Razlog3
1Institute of Integrative Medicine, University of Witten/Herdecke, Herdecke, Germany.
Complementary Medicine Research
|February 12, 2025
Summary
A new assessment tool was developed to evaluate homeopathic research quality. This tool combines scientific rigor with validity measures, enhancing evidence-based decision-making in homeopathy.
Area of Science:
- Homeopathy Research
- Scientific Methodology
- Evidence-Based Medicine
Background:
- The quality of homeopathic research is often debated.
- Improving study assessment is crucial for evidence-based clinical decisions.
- A unified tool is needed to assess scientific rigor and validity in homeopathy studies.
Purpose of the Study:
- To develop a comprehensive assessment tool for homeopathic intervention studies.
- To integrate methodological rigor with external and model validity criteria.
- To enhance the overall quality assessment of homeopathic research.
Main Methods:
- An expert panel refined a draft tool through Delphi feedback rounds.
- The preliminary tool was pilot-tested on randomly selected homeopathic studies.
- Interrater reliability was assessed using Gwet's AC2 statistic.
Main Results:
- The developed tool assesses risk-of-bias, credibility, intervention coherence, and clinical relevance.
- It uses a point system for each domain, resulting in an overall score.
- Raters found the tool useful and easy to apply, with good to moderate interrater reliability (AC2 = 0.81 and 0.64).
Conclusions:
- An applicable and reliable assessment tool for homeopathic studies has been created.
- This instrument can improve the scientific value of systematic reviews and meta-analyses in homeopathy.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
114
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
114
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:19Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
01:12Hazard Ratio
78
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
78
01:13Therapeutic Index
4.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.0K
01:11Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K